Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors

Written By David Ritter

Karen Agricola, Gabrielle Stires, Darcy A Krueger, Jamie K Capal, David N Franz, David M Ritter

Pediatr Neurol. 2021 Jul;120:7-10. doi: 10.1016/j.pediatrneurol.2021.03.007. Epub 2021 Apr 2.

Case series of patients who developed diabetes after mTOR inhibitors. Importantly, it is not a high number of patients and those who developed it often had other medication-related risk factors. Nearly all patients can be treated without stopping mTOR inhibitors.

https://www.sciencedirect.com/science/article/pii/S0887899421000539

David Ritter
Previous

Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex
Next

Acute Ataxia and Paresthesia in a Healthy 5-year-old Girl